Clinical TrialID 7224

Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis

NCT04744103

Actinic Cheilitis

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7224
Evidence Id
7224
Core Evidence Id
7224
Source Clinical Trial Id
7214
Herb2 Clinical Trial Id
HBCT007214
Nct Id
NCT04744103
Title
Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis
Status
Withdrawn
Phase
Phase 4
Study Result
No
Study Condition
Actinic Cheilitis
Study Type
Interventional
Study Design
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DRUG: TCA
Intervention Allocation
Intervention Model
Single_Group
Intervention Mask
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
0
Outcome Measure
Remission rate, Determine the remission rate of actinic cheilitis following topical TCA treatment., 3 months|Treatment Number, Establish the average number of treatments required to achieve remission., 3 months|Recurrence Rate, Determine the recurrence rate of actinic cheilitis following topical TCA treatment, 6 months|Adverse Events, Identify the common adverse events, if any, associated with topical TCA lip peels and determine their incidence., 3 months
Sponsor Collaborator
Nova Scotia Health Authority
Funded By
OTHER
Location
QEII, Halifax, Nova Scotia, B3H 2Y9, Canada
Other Id
1026120
Start Date
2023-09-15
Primary Completion Date
2023-09-15
Completion Date
2023-09-15
First Posted
2021-02-08
Results First Posted
Last Update Posted
2024-08-21
Study Document
Study Url
https://clinicaltrials.gov/study/NCT04744103
Title Cn
Title En
Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis
Bilingual Status
semi_complete